Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
VOR
Stock Latest News
The Fly
Vor Bio presents research on patients participating in CGT trials
19d ago
VOR
Premium
Company Announcements
Vor Biopharma Approves Stock Option Repricing Strategy
25d ago
8K
VOR
Premium
The Fly
Vor Bio files to sell 125.71M shares of common stock for holders
1M ago
VOR
Premium
Company Announcements
Vor Biopharma Strengthens Board with New Appointment
2M ago
8K
VOR
Premium
The Fly
Vor Bio appoints Kalir to board of directors
2M ago
VOR
Premium
The Fly
Vor Bio price target lowered to $6 from $12 at JMP Securities
2M ago
VOR
Premium
Company Announcements
Vor Biopharma Secures $55.6M for Cancer Therapy Trials
2M ago
8K
VOR
Premium
The Fly
Vor Bio prices 55.87M shares at 99.425c in private placement
2M ago
VOR
Premium
The Fly
Vor Bio trem-cel relapse-rate remains low, says Oppenheimer
3M ago
VOR
Premium
The Fly
Vor Bio announces updated data from Phase 1/2 VBP1-1 study
3M ago
VOR
Premium
Company Announcements
Vor Biopharma Reports Promising Phase 1/2 Study Results
3M ago
8K
VOR
Premium
The Fly
Vor Bio price target lowered to $8 from $10 at Oppenheimer
4M ago
VOR
Premium
The Fly
Vor Bio price target lowered to $14 from $22 at Baird
4M ago
VOR
Premium
Company Announcements
Vor Biopharma Reports Q3 2024 Financial Results
4M ago
VOR
Premium
The Fly
Vor Bio reports Q3 EPS (40c), consensus (40c)
4M ago
VOR
Premium
Company Announcements
Vor Biopharma Appoints New CFO, Enhances Leadership Team
5M ago
8K
VOR
Premium
The Fly
Vor Bio names Han Choi as CFO
5M ago
VOR
Premium
The Fly
Vor Bio announces new clinical data from VBP101 study
6M ago
VOR
Premium
Company Announcements
Vor Biopharma Advances Innovative Blood Cancer Therapies
6M ago
8K
VOR
Premium
The Fly
Vor Bio announces new data, plans to approach FDA on trial design by year-end
6M ago
VOR
Premium
The Fly
Vor Bio price target lowered to $3 from $10 at Barclays
7M ago
VOR
Premium
The Fly
Vor Bio reports Q2 EPS (41c) vs (45c) last year
7M ago
VOR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.